Thais Marques Gurgel, MD
Hospitalist · Framingham, MANPI 1831619972
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 60 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 38.5% of the total. Reporting peaked in 2019 at $406 and has fallen 66.4% since, to $137 in 2021. Among hospitalist clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 60 payments — averaging $15.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$353
- AstraZeneca$340
- Pfizer$116
- Johnson & Johnson$88
- Viiv Healthcare Company$20
What the payments were for
- Food & beverage$918100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 28 | $353 |
| AstraZeneca | 20 | $340 |
| Pfizer | 8 | $116 |
| Johnson & Johnson | 3 | $88 |
| Viiv Healthcare Company | 1 | $20 |
How this compares
$918 in reported general payments places this provider in the 95th percentile of 599 hospitalist providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naloxone Hcl | 16 | $894 |
| Cefpodoxime Proxetil | 13 | $288 |
| Pantoprazole Sodium | 23 | $159 |
| Metoprolol Succinate | 13 | $152 |
| Atorvastatin Calcium | 14 | $115 |
| Amlodipine Besylate | 12 | $106 |
| Prednisone | 28 | $64 |
| Azithromycin | 15 | $57 |
| Oxycodone Hcl | 14 | $33 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Framingham
- Sahil KheraBurlington$226K
- Jane MeiselBoston$83K
- Joongheum ParkBoston$64K
- Jishu MottaSpringfield$36K
- Shreya TrivediBoston$20K
- Sohail WaienSpringfield$6K
- Aarti GroverBoston$4K
- Leticia HelmsBoston$4K
- Rachel GoodmanBoston$4K
- Zeeshan Gulam HussainWorcester$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.